查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1555480

腦疾病模式和軟體市場，按產品類型、患者類型、適應症、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Brain Disease Modalities and Software Market, By Product Type, By Patient Type, By Indication, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023 年腦部疾病模式和軟體市場規模為 136.9032 億美元，2024 年至 2032 年複合年成長率為 5.90%。

腦疾病模式與軟體市場-市場動態

神經系統疾病的日益普及以及對更安全和非侵入性影像設備的需求預計將推動市場的成長

隨著全球人口老化，神經系統疾病的盛行率顯著上升，包括阿茲海默症、帕金森氏症、多發性硬化症和癲癇。患者人口的不斷擴大需要開發複雜的診斷和治療方法。 2021 年，神經系統疾病導致因疾病、殘疾和過早死亡（以殘疾調整生命年衡量）而損失的 4.43 億年健康壽命，使其成為全球疾病負擔的主要原因，超過心血管疾病，由健康指標與評估研究所報告。 MRI 和 PET 掃描等非侵入性影像技術為侵入性方法提供了更安全的替代方案，最大限度地降低了患者出現併發症和不適的風險，從而促進了其更廣泛的接受。此外，影像技術的進步，包括高解析度 MRI、功能性 MRI (fMRI) 和增強型 PET 掃描，為腦部疾病模式和軟體市場創造了機會。然而，有限的意識和可及性可能會對市場的成長構成挑戰。

腦疾病模式和軟體市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 5.90% 左右的複合年成長率成長

根據產品類型細分，預計腦部影像模式將在 2023 年顯示最大的市場佔有率

根據患者類型細分，兒科是 2023 年的主導類型

根據適應症細分，創傷性腦損傷（TBI）是2023年的主導類型

根據最終用戶細分，診斷影像中心是 2023 年的主導類型

按地區分類，北美是 2023 年的主要收入來源

腦疾病模式與軟體市場細分分析：

全球腦疾病模式和軟體市場根據產品類型、患者類型、適應症、最終用戶和地區進行細分。

根據產品類型，市場分為兩類：腦部分析軟體和腦部影像模式。腦成像模式佔據市場的大部分佔有率。在這個領域中，大腦成像模式對於全面了解大腦結構和功能至關重要。

根據患者類型，市場分為三組：成人、嬰兒和兒科。兒科佔據最大的市場佔有率。專業的影像模式和軟體解決方案對於兒科神經病學中有效診斷和治療年輕患者的腦部疾病至關重要。

根據適應症，市場分為八類：創傷性腦損傷（TBI）、頭痛疾病、癲癇、睡眠障礙、巴金森氏症、中風、亨丁頓舞蹈症和失智症。創傷性腦損傷（TBI）在市場上佔有最大佔有率。 TBI 是一個重要的重點領域，利用尖端的腦部影像技術和軟體解決方案來增強診斷、監測和復健。

根據最終用戶，市場分為三個不同的類別：醫院和診所、門診手術中心和診斷影像中心。其中，診斷影像中心佔市場主導地位。這些設施採用各種腦部影像技術和軟體應用程式來診斷、監測和管理神經系統疾病。

腦疾病模式與軟體市場 - 地理洞察

市場地域廣闊，涵蓋北美、拉丁美洲、歐洲、亞太地區、中東和非洲。這些領域根據對商業活動做出貢獻的國家進一步分類。北美是領先地區，這主要是由於人工智慧在醫學影像中的日益融合以及顯著的技術進步。具體來說，美國和加拿大處於將人工智慧和機器學習納入醫學影像和診斷軟體的前沿。這些創新有助於增強影像分析、提高診斷精度並最佳化工作流程，從而為北美公司提供競爭優勢。 2020 年，美國放射學會 (ACR) 接受了一項調查，評估其成員在臨床環境中人工智慧的使用情況，收到 1,427 份回复，結果顯示 33.5% 的放射科醫生在其實踐中使用人工智慧。由於醫療保健支出和採用率較高，歐洲成為市場成長的第二大地區。

腦疾病模式與軟體市場-競爭格局：

腦疾病模式和軟體市場競爭激烈，許多參與者都在努力透過創新、策略聯盟和技術進步來確保市場佔有率。公司正在研發方面進行大量投資，以創建最先進的成像模式和軟體解決方案。重點強調人工智慧和機器學習，這對於提高診斷精度和營運效率至關重要。領先公司正在收購小型企業和新創公司，以擴大其技術能力並獲得腦部疾病診斷和治療的創新成果。此外，組織正在透過滲透新的地理區域和新興市場來增強其市場影響力，從而利用對複雜腦部疾病診斷工具不斷成長的需求。

最新進展：

2022 年5 月6 日，在國際醫學磁振造影學會(ISMRM) 2022 年年會上，GE 醫療宣布透過升級和升級，進一步向其廣泛的客戶群推出其創新的深度學習影像重建解決方案AIR Recon DL 。

全球領先的健康技術實體皇家飛利浦與位於瑞典林雪平的專門從事磁振造影 (MRI) 軟體解決方案的 Synthetic MR 公司合作，今天推出了 Smart Quant Neuro 3D。這項創新發展代表了在為多發性硬化症 (MS)、創傷性腦損傷 (TBI) 和失智症等神經系統疾病的診斷和治療評估提供客觀決策支援方面取得的重大進展。

目錄

第 1 章：腦疾病模式與軟體市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的腦疾病模式與軟體市場片段
    • 按患者類型分類的腦疾病模式和軟體市場片段
    • 依適應症分類的腦疾病模式與軟體市場片段
    • 最終用戶的腦疾病模式與軟體市場片段
    • 按國家/地區分類的腦疾病模式和軟體市場片段
    • 按地區分類的腦疾病模式和軟體市場片段
  • 競爭洞察

第 3 章：腦疾病模式與軟體主要市場趨勢

  • 腦疾病模式與軟體市場促進因素
    • 市場促進因素的影響分析
  • 腦疾病模式與軟體市場限制
    • 市場限制影響分析
  • 腦疾病治療方式與軟體市場機會
  • 腦疾病模式與軟體市場未來趨勢

第 4 章：腦疾病模式與軟體產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：腦疾病模式與軟體市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：腦疾病模式與軟體市場格局

  • 2023 年腦部疾病模式與軟體市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：腦疾病模式與軟體市場 - 按產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 大腦分析軟體
    • 腦部影像方式
      • CT設備
      • 核磁共振設備
      • PET設備
      • 正子電腦斷層掃描
      • PET-MRI

第 8 章：腦疾病模式與軟體市場 - 依病患類型

  • 概述
    • 按患者類型分類的細分市場佔有率分析
    • 成年人
    • 嬰兒
    • 兒科

第 9 章：腦疾病模式與軟體市場 - 按適應症

  • 概述
    • 按指標分類的細分市場佔有率分析
    • 創傷性腦損傷 (TBI)
    • 頭痛疾病
    • 癲癇
    • 睡眠障礙
    • 帕金森氏症
    • 中風
    • 亨丁頓舞蹈症
    • 失智

第 10 章：腦疾病模式與軟體市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院和診所
    • 門診手術中心
    • 診斷影像中心

第 11 章：腦疾病模式與軟體市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美腦部疾病治療方式與軟體主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按患者類型）
    • 北美市場規模和預測（按指標）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲腦疾病治療方式與軟體主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按患者類型）
    • 歐洲市場規模與預測（按指標）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區腦疾病治療方式及軟體主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模和預測（按患者類型）
    • 亞太地區市場規模與預測（依指標）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲腦部疾病治療方式與軟體主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按患者類型）
    • 拉丁美洲市場規模與預測（按指標）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲腦部疾病治療方式和軟體主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按患者類型）
    • 中東和非洲市場規模及預測（依指標）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 腦疾病模式與軟體產業

  • 競爭儀表板
  • 公司簡介
    • Quantib
    • Brainomix
    • Qure.ai
    • GE Company
    • Imaging Biometrics, LLC
    • United Imaging Healthcare Co. Ltd.
    • Siemens
    • Healthineers AG
    • KONINKLIJKE PHILIPS ELECTRONICS NV
    • Canon Inc.
    • VUNO Inc.
    • Aspect Imaging
    • IXICO
    • QMENTA
    • Cortechs.ai
    • AI Analysis, Inc.
    • FUJIFILM Holdings Corporation
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3594

REPORT HIGHLIGHT

Brain Disease Modalities and Software Market size was valued at USD 13,690.32 Million in 2023, expanding at a CAGR of 5.90% from 2024 to 2032.

The diagnosis of brain diseases through the use of multiple imaging modalities has demonstrated enhanced effectiveness when compared to the application of a single modality. However, the availability of multi-modal data in clinical practice is often limited due to financial constraints or the associated risks of radiation exposure. The modalities and software utilized for brain disease encompass a diverse range of technologies and applications aimed at diagnosing, monitoring, and treating various neurological disorders. These tools are vital in contemporary neurology, offering extensive diagnostic capabilities, supporting research initiatives, and improving treatment and rehabilitation results for patients suffering from neurological conditions.

Brain Disease Modalities and Software Market- Market Dynamics

The increasing prevalence of neurological disorders and demands for safer and non-invasive imaging devices is expected to drive the growth of the market

With the aging of the global population, there is a notable rise in the prevalence of neurological disorders, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy. This expanding demographic of patients necessitates the development of sophisticated diagnostic and therapeutic approaches. In 2021, neurological disorders accounted for 443 million years of healthy life lost due to illness, disability, and premature mortality (measured in disability-adjusted life years), positioning them as the leading cause of the global disease burden, surpassing cardiovascular diseases, as reported by the Institute for Health Metrics and Evaluation. Non-invasive imaging techniques, such as MRI and PET scans, present a safer alternative to invasive methods, minimizing the risk of complications and discomfort for patients, which in turn promotes their wider acceptance. Additionally, advancements in imaging technologies, including high-resolution MRI, functional MRI (fMRI), and enhanced PET scans, create opportunities for the Brain Disease Modalities and Software market. However, limited awareness and accessibility may pose challenges to the market's growth.

Brain Disease Modalities and Software Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2024-2032)

Based on product type segmentation, Brain Imaging Modalities was predicted to show maximum market share in the year 2023

Based on Patient Type segmentation, Pediatrics was the leading type in 2023

Based on Indication segmentation, Traumatic Brain Injury (TBI) was the leading type in 2023

Based on End-User segmentation, Diagnostic Imaging Centers were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Brain Disease Modalities and Software Market- Segmentation Analysis:

The Global Brain Disease Modalities and Software Market is segmented based on Product Type, Patient Type, Indication, End-User, and Region.

The market is segmented into two categories according to product type: Brain Analysis Software and Brain Imaging Modalities. Brain Imaging Modalities holds the majority share in the market. Within this sector, brain imaging modalities are crucial in offering a comprehensive understanding of brain structure and function.

The market is segmented into three groups according to Patient Type: Adults, Infants, and Pediatrics. Pediatrics holds the largest share of the market. Specialized imaging modalities and software solutions are essential in pediatric neurology to effectively diagnose and treat brain diseases in young patients.

The market is segmented into eight categories according to Indication: Traumatic Brain Injury (TBI), Headache disorders, Epilepsy, Sleep disorders, Parkinson's disease, Stroke, Huntington's disease, and Dementia. Traumatic Brain Injury (TBI) holds the largest share in the market. TBI is a significant focus area where cutting-edge brain imaging technologies and software solutions are utilized to enhance diagnosis, monitoring, and rehabilitation.

The market is segmented into three distinct categories according to the End-User: Hospitals and Clinics, Ambulatory Surgery Centers, and Diagnostic Imaging Centers. Among these, Diagnostic Imaging Centers hold a dominant position in the market. These facilities employ various brain imaging techniques and software applications to diagnose, monitor, and manage neurological disorders.

Brain Disease Modalities and Software Market- Geographical Insights

This market is geographically extensive, encompassing North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These areas are further categorized based on the countries contributing to business activities. North America is the leading region, primarily due to the increasing integration of artificial intelligence in medical imaging and significant technological advancements. Specifically, the United States and Canada are at the forefront of incorporating AI and machine learning into medical imaging and diagnostic software. These innovations facilitate enhanced image analysis, boost diagnostic precision, and optimize workflows, thereby providing North American firms with a competitive advantage. In 2020, the American College of Radiology (ACR) was surveyed to assess the utilization of AI among its members in clinical settings, receiving 1,427 responses, which revealed that 33.5% of radiologists were employing AI in their practices. Europe ranks as the second-largest region for market growth, attributed to high healthcare expenditure and adoption rates.

Brain Disease Modalities and Software Market- Competitive Landscape:

The Brain Disease Modalities and Software Market exhibits a high level of competition, with a multitude of participants striving to secure market share through innovation, strategic alliances, and advancements in technology. Companies are making substantial investments in research and development to create state-of-the-art imaging modalities and software solutions. Significant emphasis is placed on artificial intelligence and machine learning, which are pivotal in improving diagnostic precision and operational efficiency. Leading firms are acquiring smaller enterprises and startups to broaden their technological capabilities and access novel innovations in the diagnosis and treatment of brain diseases. Additionally, organizations are enhancing their market presence by penetrating new geographic territories and emerging markets, thereby leveraging the increasing demand for sophisticated brain disease diagnostic tools.

Recent Developments:

On May 6, 2022, during the International Society for Magnetic Resonance in Medicine (ISMRM) 2022 Annual Meeting, GE Healthcare announced the further advancement of its innovative deep learning image reconstruction solution, AIR Recon DL, to its extensive customer base through both upgrades and new purchases across its MR product portfolio.

Royal Philips, a prominent global entity in health technology, in collaboration with Synthetic MR, a company specializing in magnetic resonance imaging (MRI) software solutions based in Linkoping, Sweden, has today unveiled Smart Quant Neuro 3D. This innovative development represents a significant progression in providing objective decision support for the diagnosis and therapeutic evaluation of neurological conditions such as multiple sclerosis (MS), traumatic brain injury (TBI), and dementia.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Quantib
  • Brainomix
  • Qure.ai
  • GE Company
  • Imaging Biometrics, LLC
  • United Imaging Healthcare Co. Ltd.
  • Siemens
  • Healthineers AG
  • KONINKLIJKE PHILIPS ELECTRONICS NV
  • Canon Inc.
  • VUNO Inc.
  • Aspect Imaging
  • IXICO
  • QMENTA
  • Cortechs.ai
  • A.I. Analysis, Inc.
  • FUJIFILM Holdings Corporation
  • Others

GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Brain Analysis Software
  • Brain Imaging Modalities
  • CT Devices
  • MRI Devices
  • PET Devices
  • PET-CT
  • PET-MRI

GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET, BY PATIENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Adults
  • Infants
  • Pediatrics

GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Traumatic Brain Injury (TBI)
  • Headache disorders
  • Epilepsy
  • Sleep disorders
  • Parkinson's disease
  • Stroke
  • Huntington's disease
  • Dementia

GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics
  • Ambulatory Surgery Centers
  • Diagnostic Imaging Centers

GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Brain Disease Modalities and Software Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Brain Disease Modalities and Software Market Snippet by Product Type
    • 2.1.2. Brain Disease Modalities and Software Market Snippet by Patient Type
    • 2.1.3. Brain Disease Modalities and Software Market Snippet by Indication
    • 2.1.4. Brain Disease Modalities and Software Market Snippet by End-User
    • 2.1.5. Brain Disease Modalities and Software Market Snippet by Country
    • 2.1.6. Brain Disease Modalities and Software Market Snippet by Region
  • 2.2. Competitive Insights

3. Brain Disease Modalities and Software Key Market Trends

  • 3.1. Brain Disease Modalities and Software Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Brain Disease Modalities and Software Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Brain Disease Modalities and Software Market Opportunities
  • 3.4. Brain Disease Modalities and Software Market Future Trends

4. Brain Disease Modalities and Software Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Brain Disease Modalities and Software Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Brain Disease Modalities and Software Market Landscape

  • 6.1. Brain Disease Modalities and Software Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Brain Disease Modalities and Software Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Brain Analysis Software
    • 7.1.3. Brain Imaging Modalities
      • 7.1.3.1. CT Devices
      • 7.1.3.2. MRI Devices
      • 7.1.3.3. PET Devices
      • 7.1.3.4. PET-CT
      • 7.1.3.5. PET-MRI

8. Brain Disease Modalities and Software Market - By Patient Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Patient Type, 2023 & 2032 (%)
    • 8.1.2. Adults
    • 8.1.3. Infants
    • 8.1.4. Paediatrics

9. Brain Disease Modalities and Software Market - By Indication

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 9.1.2. Traumatic Brain Injury (TBI)
    • 9.1.3. Headache disorders
    • 9.1.4. Epilepsy
    • 9.1.5. Sleep disorders
    • 9.1.6. Parkinson's disease
    • 9.1.7. Stroke
    • 9.1.8. Huntington's disease
    • 9.1.9. Dementia

10. Brain Disease Modalities and Software Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals and Clinics
    • 10.1.3. Ambulatory Surgery Centers
    • 10.1.4. Diagnostic Imaging Centers

11. Brain Disease Modalities and Software Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Brain Disease Modalities and Software Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Brain Disease Modalities and Software Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Brain Disease Modalities and Software Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Brain Disease Modalities and Software Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Brain Disease Modalities and Software Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Brain Disease Modalities and Software Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Quantib
    • 12.2.2. Brainomix
    • 12.2.3. Qure.ai
    • 12.2.4. GE Company
    • 12.2.5. Imaging Biometrics, LLC
    • 12.2.6. United Imaging Healthcare Co. Ltd.
    • 12.2.7. Siemens
    • 12.2.8. Healthineers AG
    • 12.2.9. KONINKLIJKE PHILIPS ELECTRONICS NV
    • 12.2.10. Canon Inc.
    • 12.2.11. VUNO Inc.
    • 12.2.12. Aspect Imaging
    • 12.2.13. IXICO
    • 12.2.14. QMENTA
    • 12.2.15. Cortechs.ai
    • 12.2.16. A.I. Analysis, Inc.
    • 12.2.17. FUJIFILM Holdings Corporation
    • 12.2.18. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us